CoChat
Sign Up
Cited by 202

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents

Xia, Xiaohuan, Wang, Yi, Huang, Yunlong, Zhang, Han, Lu, Hongfang, Zheng, Jialin C.·2019·Progress in Neurobiology
DOI 10.1016/j.pneurobio.2019.101694PMC PMC7323939
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2019.101694

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 228

  1. Abbott, 2013, Blood-brain barrier structure and function and the challenges for CNS drug delivery, J. Inherit. Metab. Dis., 36, 437, 10.1007/s10545-013-9608-0 · DOI
  2. Al-Nedawi, 2008, Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nat. Cell Biol., 10, 619, 10.1038/ncb1725 · DOI
  3. Almutairi, 2016, Factors controlling permeability of the blood-brain barrier, Cell. Mol. Life Sci., 73, 57, 10.1007/s00018-015-2050-8 · DOI
  4. Alvarez-Erviti, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat. Biotechnol., 29, 341, 10.1038/nbt.1807 · DOI · Paper page
  5. Alvarez, 2012, Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers, Kidney Int., 82, 1024, 10.1038/ki.2012.256 · DOI
  6. Ambros, 2001, microRNAs: tiny regulators with great potential, Cell, 107, 823, 10.1016/S0092-8674(01)00616-X · DOI
  7. An, 2013, microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma, PLoS One, 8, 10.1371/journal.pone.0069478 · DOI
  8. Asai, 2015, Depletion of microglia and inhibition of exosome synthesis halt tau propagation, Nat. Neurosci., 18, 1584, 10.1038/nn.4132 · DOI · Paper page
  9. Baranova, 2007, Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia, J. Neurosci., 27, 6320, 10.1523/JNEUROSCI.0449-07.2007 · DOI
  10. Batiz, 2015, Exosomes as novel regulators of adult neurogenic niches, Front. Cell. Neurosci., 9, 501
  11. Benilova, 2012, The toxic Abeta oligomer and Alzheimer’s disease: an emperor in need of clothes, Nat. Neurosci., 15, 349, 10.1038/nn.3028 · DOI · Paper page
  12. Bergfield, 2010, Age-related networks of regional covariance in MRI gray matter: reproducible multivariate patterns in healthy aging, Neuroimage, 49, 1750, 10.1016/j.neuroimage.2009.09.051 · DOI
  13. Bergsmedh, 2001, Horizontal transfer of oncogenes by uptake of apoptotic bodies, Proc. Natl. Acad. Sci. U. S. A., 98, 6407, 10.1073/pnas.101129998 · DOI · Paper page
  14. Bernal-Pacheco, 2012, Nonmotor manifestations in Parkinson disease, Neurologist, 18, 1, 10.1097/NRL.0b013e31823d7abb · DOI
  15. Blank, 1981, Ribonucleases of human serum, urine, cerebrospinal fluid, and leukocytes. Activity staining following electrophoresis in sodium dodecyl sulfate-polyacrylamide gels, Biochemistry, 20, 2261, 10.1021/bi00511a030 · DOI
  16. Blann, 2002, Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?, Stroke, 33, 2141, 10.1161/01.STR.0000029008.00497.D3 · DOI
  17. Boerrigter, 1992, DNA repair and Alzheimer’s disease, J. Gerontol., 47, B177, 10.1093/geronj/47.6.B177 · DOI
  18. Bos, 2009, Genes that mediate breast cancer metastasis to the brain, Nature, 459, 1005, 10.1038/nature08021 · DOI · Paper page
  19. Bushati, 2007, microRNA functions, Annu. Rev. Cell Dev. Biol., 23, 175, 10.1146/annurev.cellbio.23.090506.123406 · DOI · Paper page
  20. Cai, 2017, Let7b modulates the Wnt/beta-catenin pathway in liver cancer cells via downregulated Frizzled4, Tumour Biol., 39, 10.1177/1010428317716076 · DOI
  21. Cameron, 2010, Inflammation, microglia, and Alzheimer’s disease, Neurobiol. Dis., 37, 503, 10.1016/j.nbd.2009.10.006 · DOI
  22. Cao, 2017, MicroRNA biomarkers of Parkinson’s disease in serum exosome-like microvesicles, Neurosci. Lett., 644, 94, 10.1016/j.neulet.2017.02.045 · DOI
  23. Chang, 2013, SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging, Cell, 153, 1448, 10.1016/j.cell.2013.05.027 · DOI · Paper page
  24. Chen, 2015, Effects of focal cerebral ischemia on exosomal versus serum miR126, Transl. Stroke Res., 6, 478, 10.1007/s12975-015-0429-3 · DOI
  25. Chen, 2001, Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats, Stroke, 32, 1005, 10.1161/01.STR.32.4.1005 · DOI
  26. Chen, 2017, Potential roles of exosomal MicroRNAs as diagnostic biomarkers and therapeutic application in Alzheimer’s disease, Neural Plast., 2017, 10.1155/2017/7027380 · DOI · Paper page
  27. Chen, 2014, Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells, Hepatology, 59, 1118, 10.1002/hep.26768 · DOI
  28. Cheng, 2015, Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment, Mol. Psychiatry, 20, 1188, 10.1038/mp.2014.127 · DOI · Paper page
  29. Cheng, 2014, Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood, J. Extracell. Vesicles, 3, 10.3402/jev.v3.23743 · DOI · Paper page
  30. Cheng, 2014, Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine, Kidney Int., 86, 433, 10.1038/ki.2013.502 · DOI
  31. Conti, 2012, REST controls self-renewal and tumorigenic competence of human glioblastoma cells, PLoS One, 7, 10.1371/journal.pone.0038486 · DOI
  32. Coppede, 2010, DNA repair in premature aging disorders and neurodegeneration, Curr. Aging Sci., 3, 3, 10.2174/1874609811003010003 · DOI
  33. Courchesne, 2000, Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers, Radiology, 216, 672, 10.1148/radiology.216.3.r00au37672 · DOI · Paper page
  34. Crescitelli, 2013, Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes, J. Extracell. Vesicles, 2, 10.3402/jev.v2i0.20677 · DOI · Paper page
  35. D’Asti, 2012, Oncogenic extracellular vesicles in brain tumor progression, Front. Physiol., 3, 294, 10.3389/fphys.2012.00294 · DOI
  36. Danborg, 2014, The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review, Biomarkers, 19, 259, 10.3109/1354750X.2014.904001 · DOI
  37. de Rijk, 2000, Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, 54, S21
  38. Denzer, 2000, Exosome: from internal vesicle of the multivesicular body to intercellular signaling device, J. Cell. Sci., 113, 3365, 10.1242/jcs.113.19.3365 · DOI
  39. Devinsky, 2003, Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment, Epilepsy Behav., 4, S2, 10.1016/j.yebeh.2003.10.002 · DOI
  40. Ding, 2018, Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling, Anal. Bioanal. Chem., 410, 3805, 10.1007/s00216-018-1052-4 · DOI
  41. Dinkins, 2014, Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease, Neurobiol. Aging, 35, 1792, 10.1016/j.neurobiolaging.2014.02.012 · DOI · Paper page
  42. Doxakis, 2010, Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153, J. Biol. Chem., 285, 12726, 10.1074/jbc.M109.086827 · DOI · Paper page
  43. Ebrahimkhani, 2017, Exosomal microRNA signatures in multiple sclerosis reflect disease status, Sci. Rep., 7, 14293, 10.1038/s41598-017-14301-3 · DOI
  44. Fancy, 2009, Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS, Genes Dev., 23, 1571, 10.1101/gad.1806309 · DOI · Paper page
  45. Fleshner, 2017, Exosomes, DAMPs and miRNA: features of stress physiology and immune homeostasis, Trends Immunol., 38, 768, 10.1016/j.it.2017.08.002 · DOI
  46. Fox, 2011, Epidemiology of metastatic brain tumors, Neurosurg. Clin. N. Am., 22, 1, 10.1016/j.nec.2010.08.007 · DOI
  47. Galpern, 2006, Interface between tauopathies and synucleinopathies: a tale of two proteins, Ann. Neurol., 59, 449, 10.1002/ana.20819 · DOI
  48. Gauthier, 2017, Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities, Acta Neuropathol. Commun., 5, 65, 10.1186/s40478-017-0466-0 · DOI
  49. Goetzl, 2015, Low neural exosomal levels of cellular survival factors in Alzheimer’s disease, Ann. Clin. Transl. Neurol., 2, 769, 10.1002/acn3.211 · DOI
  50. Goetzl, 2015, Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease, Neurology, 85, 40, 10.1212/WNL.0000000000001702 · DOI · Paper page
  51. Goetzl, 2016, Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease, FASEB J., 30, 3853, 10.1096/fj.201600756R · DOI · Paper page
  52. Gotanda, 2016, Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines, Sci. Rep., 6, 32299, 10.1038/srep32299 · DOI
  53. Grant, 2009, Pathways and mechanisms of endocytic recycling, Nat. Rev. Mol. Cell Biol., 10, 597, 10.1038/nrm2755 · DOI · Paper page
  54. Guescini, 2010, Astrocytes and Glioblastoma cells release exosomes carrying mtDNA, J. Neural Transm. (Vienna), 117, 1, 10.1007/s00702-009-0288-8 · DOI
  55. Gui, 2015, Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease, Oncotarget, 6, 37043, 10.18632/oncotarget.6158 · DOI · Paper page
  56. Gveric, 1999, Insulin-like growth factors and binding proteins in multiple sclerosis plaques, Neuropathol. Appl. Neurobiol., 25, 215, 10.1046/j.1365-2990.1999.00187.x · DOI
  57. Haney, 2015, Exosomes as drug delivery vehicles for Parkinson’s disease therapy, J. Control. Release, 207, 18, 10.1016/j.jconrel.2015.03.033 · DOI · Paper page
  58. Harding, 1983, Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing, Biochem. Biophys. Res. Commun., 113, 650, 10.1016/0006-291X(83)91776-X · DOI
  59. Helwa, 2017, A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents, PLoS One, 12, 10.1371/journal.pone.0170628 · DOI
  60. Heman-Ackah, 2013, RISC in PD: the impact of microRNAs in Parkinson’s disease cellular and molecular pathogenesis, Front. Mol. Neurosci., 6, 40, 10.3389/fnmol.2013.00040 · DOI
  61. Heneka, 2007, Inflammatory processes in Alzheimer’s disease, J. Neuroimmunol., 184, 69, 10.1016/j.jneuroim.2006.11.017 · DOI · Paper page
  62. Hijazi, 2016, The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation, Eur. Heart J., 37, 1582, 10.1093/eurheartj/ehw054 · DOI · Paper page
  63. Hirsch, 2009, Neuroinflammation in Parkinson’s disease: a target for neuroprotection?, Lancet Neurol., 8, 382, 10.1016/S1474-4422(09)70062-6 · DOI · Paper page
  64. Hsu, 2010, Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C, J. Cell Biol., 189, 223, 10.1083/jcb.200911018 · DOI
  65. Hu, 2012, MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus, BMC Neurosci., 13, 115, 10.1186/1471-2202-13-115 · DOI
  66. Huang, 2018, Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons, FASEB J., 32, 512, 10.1096/fj.201700673r · DOI · Paper page
  67. Ingram, 2010, Complement regulator factor H as a serum biomarker of multiple sclerosis disease state, Brain, 133, 1602, 10.1093/brain/awq085 · DOI
  68. Jaeger, 2008, Functional role of lipoprotein receptors in Alzheimer’s disease, Curr. Alzheimer Res., 5, 15, 10.2174/156720508783884675 · DOI
  69. Jaiswal, 2002, Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells, J. Cell Biol., 159, 625, 10.1083/jcb.200208154 · DOI
  70. Jeppesen, 2014, Comparative analysis of discrete exosome fractions obtained by differential centrifugation, J. Extracell. Vesicles, 3, 25011, 10.3402/jev.v3.25011 · DOI
  71. Ji, 2016, Increased brain-specific MiR-9 and MiR-124 in the serum exosomes of acute ischemic stroke patients, PLoS One, 11, 10.1371/journal.pone.0163645 · DOI
  72. Jimenez-Mateos, 2011, miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132, Am. J. Pathol., 179, 2519, 10.1016/j.ajpath.2011.07.036 · DOI
  73. Jimenez-Mateos, 2012, Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects, Nat. Med., 18, 1087, 10.1038/nm.2834 · DOI
  74. Jin, 2016, Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway, BMC Cancer, 16, 863, 10.1186/s12885-016-2904-y · DOI
  75. Junker, 2009, MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47, Brain, 132, 3342, 10.1093/brain/awp300 · DOI · Paper page
  76. Kalani, 2014, Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics, Mol. Neurobiol., 49, 590, 10.1007/s12035-013-8544-1 · DOI
  77. Kalaria, 2016, Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease, Acta Neuropathol., 131, 659, 10.1007/s00401-016-1571-z · DOI · Paper page
  78. Kalia, 2015, Parkinson’s disease, Lancet, 386, 896, 10.1016/S0140-6736(14)61393-3 · DOI · Paper page
  79. Kan, 2009, The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim, Gastroenterology, 136, 1689, 10.1053/j.gastro.2009.02.002 · DOI
  80. Katakowski, 2013, Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth, Cancer Lett., 335, 201, 10.1016/j.canlet.2013.02.019 · DOI · Paper page
  81. Keller, 2011, Body fluid derived exosomes as a novel template for clinical diagnostics, J. Transl. Med., 9, 86, 10.1186/1479-5876-9-86 · DOI
  82. Kim, 2013, EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles, J. Extracell. Vesicles, 2, 10.3402/jev.v2i0.20384 · DOI
  83. Kimura, 2018, Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis, Nat. Commun., 9, 17, 10.1038/s41467-017-02406-2 · DOI
  84. Kimura, 2016, Disrupted balance of T cells under natalizumab treatment in multiple sclerosis, Neurol. Neuroimmunol. Neuroinflamm., 3, e210, 10.1212/NXI.0000000000000210 · DOI
  85. Kojima, 2018, Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment, Nat. Commun., 9, 1305, 10.1038/s41467-018-03733-8 · DOI · Paper page
  86. Kumar, 2016, Are circulating microRNAs peripheral biomarkers for Alzheimer’s disease?, Biochim. Biophys. Acta, 1862, 1617, 10.1016/j.bbadis.2016.06.001 · DOI
  87. Kuss, 2008, MicroRNAs in brain function and disease, Curr. Neurol. Neurosci. Rep., 8, 190, 10.1007/s11910-008-0031-0 · DOI
  88. Lachenal, 2011, Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity, Mol. Cell. Neurosci., 46, 409, 10.1016/j.mcn.2010.11.004 · DOI
  89. Lan, 2018, Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma, Cell. Oncol. (Dordr.), 41, 25, 10.1007/s13402-017-0355-3 · DOI
  90. Lang, 2017, Mesenchymal stem cells as natural bio-factories for exosomes carrying miR-124a in the treatment of gliomas, Neuro Oncol.
  91. Lawson, 2013, p38alpha mitogen-activated protein kinase depletion and repression of signal transduction to translation machinery by miR-124 and -128 in neurons, Mol. Cell. Biol., 33, 127, 10.1128/MCB.00695-12 · DOI
  92. Lee, 2017, 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders, J. Biomed. Sci., 24, 59, 10.1186/s12929-017-0362-8 · DOI
  93. Lee, 2017, Exosome-based delivery of miR-124 in a Huntington’s disease model, J. Mov. Disord., 10, 45, 10.14802/jmd.16054 · DOI · Paper page
  94. Lee, 2011, Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular’ debris’, Semin. Immunopathol., 33, 455, 10.1007/s00281-011-0250-3 · DOI
  95. Lee, 2012, Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy, Hum. Mol. Genet., 21, R125, 10.1093/hmg/dds317 · DOI
  96. Lees, 2009, Parkinson’s disease, Lancet, 373, 2055, 10.1016/S0140-6736(09)60492-X · DOI · Paper page
  97. Leggio, 2017, microRNAs in parkinson’s disease: from pathogenesis to novel diagnostic and therapeutic approaches, Int. J. Mol. Sci., 18, 10.3390/ijms18122698 · DOI
  98. Lei, 2014, miR-21 induces cell proliferation and suppresses the chemosensitivity in glioblastoma cells via downregulation of FOXO1, Int. J. Clin. Exp. Med., 7, 2060
  99. Li, 2017, Plasma exosomal miR-422a and miR-125b-2-3p serve as biomarkers for ischemic stroke, Curr. Neurovasc. Res.
  100. Li, 2018, Plasma exosomal miRNA-122-5p and miR-300-3p as potential markers for transient ischaemic attack in rats, Front. Aging Neurosci., 10, 24, 10.3389/fnagi.2018.00024 · DOI
  101. Li, 2014, MicroRNA-144 is a circulating effector of remote ischemic preconditioning, Basic Res. Cardiol., 109, 423, 10.1007/s00395-014-0423-z · DOI
  102. Li, 2016, Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner, Neurobiol. Dis., 91, 221, 10.1016/j.nbd.2016.03.018 · DOI
  103. Li, 2012, Deep sequencing and microarray hybridization identify conserved and species-specific microRNAs during somatic embryogenesis in hybrid yellow poplar, PLoS One, 7
  104. Li, 2005, Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease, Hum. Mutat., 25, 270, 10.1002/humu.20138 · DOI
  105. Liang, 2007, Characterization of microRNA expression profiles in normal human tissues, BMC Genomics, 8, 166, 10.1186/1471-2164-8-166 · DOI · Paper page
  106. Liu, 2014, MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer’s disease, Mol. Med. Rep., 10, 2395, 10.3892/mmr.2014.2484 · DOI · Paper page
  107. Liu, 2013, MicroRNA-17-92 cluster mediates the proliferation and survival of neural progenitor cells after stroke, J. Biol. Chem., 288, 12478, 10.1074/jbc.M112.449025 · DOI
  108. Llorente, 2013, Molecular lipidomics of exosomes released by PC-3 prostate cancer cells, Biochim. Biophys. Acta, 1831, 1302, 10.1016/j.bbalip.2013.04.011 · DOI
  109. Logan, 2006, A critical role for vesicle-associated membrane protein-7 in exocytosis from human eosinophils and neutrophils, Allergy, 61, 777, 10.1111/j.1398-9995.2006.01089.x · DOI · Paper page
  110. Lopez-Ramirez, 2014, MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation, FASEB J., 28, 2551, 10.1096/fj.13-248880 · DOI · Paper page
  111. Lu, 2014, REST and stress resistance in ageing and Alzheimer’s disease, Nature, 507, 448, 10.1038/nature13163 · DOI
  112. Lugli, 2015, Plasma exosomal miRNAs in persons with and without alzheimer disease: altered expression and prospects for biomarkers, PLoS One, 10, 10.1371/journal.pone.0139233 · DOI · Paper page
  113. Ma, 2019, Exosomes released from neural progenitor cells and induced neural progenitor cells regulate neurogenesis through miR-21a, Cell Commun. Signal, 17, 96, 10.1186/s12964-019-0418-3 · DOI
  114. Ma, 2018, Induced neural progenitor cells abundantly secrete extracellular vesicles and promote the proliferation of neural progenitors via extracellular signal-regulated kinase pathways, Neurobiol. Dis., 124, 322, 10.1016/j.nbd.2018.12.003 · DOI
  115. Madelaine, 2017, MicroRNA-9 couples brain neurogenesis and angiogenesis, Cell Rep., 20, 1533, 10.1016/j.celrep.2017.07.051 · DOI
  116. Malone, 2011, Microarrays, deep sequencing and the true measure of the transcriptome, BMC Biol., 9, 34, 10.1186/1741-7007-9-34 · DOI
  117. Manna, 2018, Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients, FASEB J., 32, 4241, 10.1096/fj.201701533R · DOI
  118. Manterola, 2014, A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool, Neuro Oncol, 16, 520, 10.1093/neuonc/not218 · DOI
  119. Markesbery, 1997, Oxidative stress hypothesis in Alzheimer’s disease, Free Radic. Biol. Med., 23, 134, 10.1016/S0891-5849(96)00629-6 · DOI · Paper page
  120. Mason, 2003, Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination, J. Neurosci., 23, 7710, 10.1523/JNEUROSCI.23-20-07710.2003 · DOI · Paper page
  121. Mathivanan, 2012, ExoCarta 2012: database of exosomal proteins, RNA and lipids, Nucleic Acids Res., 40, D1241, 10.1093/nar/gkr828 · DOI
  122. Mathivanan, 2010, Exosomes: extracellular organelles important in intercellular communication, J. Proteomics, 73, 1907, 10.1016/j.jprot.2010.06.006 · DOI
  123. Mathivanan, 2009, ExoCarta: a compendium of exosomal proteins and RNA, Proteomics, 9, 4997, 10.1002/pmic.200900351 · DOI
  124. McKee, 2016, Emerging roles for the immune system in traumatic brain injury, Front. Immunol., 7, 556, 10.3389/fimmu.2016.00556 · DOI
  125. McKenzie, 2016, KRAS-MEK signaling controls Ago2 sorting into exosomes, Cell Rep., 15, 978, 10.1016/j.celrep.2016.03.085 · DOI
  126. McKiernan, 2012, Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death, Exp. Neurol., 237, 346, 10.1016/j.expneurol.2012.06.029 · DOI
  127. Melo, 2014, Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis, Cancer Cell, 26, 707, 10.1016/j.ccell.2014.09.005 · DOI
  128. Miranda, 2010, Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease, Kidney Int., 78, 191, 10.1038/ki.2010.106 · DOI
  129. Mishra, 2013, HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells, J. Neurosci., 33, 5992, 10.1523/JNEUROSCI.4796-12.2013 · DOI · Paper page
  130. Moncini, 2017, The miR-15/107 family of microRNA genes regulates CDK5R1/p35 with implications for alzheimer’s disease pathogenesis, Mol. Neurobiol., 54, 4329, 10.1007/s12035-016-0002-4 · DOI
  131. Montecalvo, 2012, Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes, Blood, 119, 756, 10.1182/blood-2011-02-338004 · DOI · Paper page
  132. Morelli, 2004, Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells, Blood, 104, 3257, 10.1182/blood-2004-03-0824 · DOI
  133. Morris, 2005, Mild cognitive impairment (MCI) represents early-stage Alzheimer’s disease, J. Alzheimers Dis., 7, 235, 10.3233/JAD-2005-7306 · DOI
  134. Morton, 2018, Neonatal subventricular zone neural stem cells release extracellular vesicles that act as a microglial morphogen, Cell Rep., 23, 78, 10.1016/j.celrep.2018.03.037 · DOI · Paper page
  135. Moshe, 2015, Epilepsy: new advances, Lancet, 385, 884, 10.1016/S0140-6736(14)60456-6 · DOI
  136. Nampoothiri, 2019, miR-9 upregulation integrates post-ischemic neuronal survival and regeneration in vitro, Cell. Mol. Neurobiol., 39, 223, 10.1007/s10571-018-0642-1 · DOI
  137. Nicholas, 2013, Multiple sclerosis, Am. Fam. Phys., 87, 712
  138. Ohno, 2013, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells, Mol. Ther., 21, 185, 10.1038/mt.2012.180 · DOI · Paper page
  139. Pan, 1983, Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor, Cell, 33, 967, 10.1016/0092-8674(83)90040-5 · DOI
  140. Pardridge, 2012, Drug transport across the blood-brain barrier, J. Cereb. Blood Flow Metab., 32, 1959, 10.1038/jcbfm.2012.126 · DOI · Paper page
  141. Parsi, 2015, Preclinical evaluation of miR-15/107 family members as multifactorial drug targets for alzheimer’s disease, Mol. Ther. Nucleic Acids, 4, e256, 10.1038/mtna.2015.33 · DOI · Paper page
  142. Peng, 2013, Preformed albumin corona, a protective coating for nanoparticles based drug delivery system, Biomaterials, 34, 8521, 10.1016/j.biomaterials.2013.07.102 · DOI · Paper page
  143. Persengiev, 2012, The impact of MicroRNAs on brain aging and neurodegeneration, Curr. Gerontol. Geriatr. Res., 2012, 10.1155/2012/359369 · DOI
  144. Piazzini, 2001, Depression and anxiety in patients with epilepsy, Epilepsy Behav., 2, 481, 10.1006/ebeh.2001.0247 · DOI
  145. Poliakov, 2009, Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen, Prostate, 69, 159, 10.1002/pros.20860 · DOI
  146. Pols, 2009, Trafficking and function of the tetraspanin CD63, Exp. Cell Res., 315, 1584, 10.1016/j.yexcr.2008.09.020 · DOI · Paper page
  147. Pusic, 2014, Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination, Glia, 62, 284, 10.1002/glia.22606 · DOI
  148. Pusic, 2014, What are exosomes and how can they be used in multiple sclerosis therapy?, Expert Rev. Neurother., 14, 353, 10.1586/14737175.2014.890893 · DOI
  149. Pusic, 2016, Environmental enrichment stimulates immune cell secretion of exosomes that promote CNS myelination and may regulate inflammation, Cell. Mol. Neurobiol., 36, 313, 10.1007/s10571-015-0269-4 · DOI
  150. Quail, 2013, Microenvironmental regulation of tumor progression and metastasis, Nat. Med., 19, 1423, 10.1038/nm.3394 · DOI · Paper page
  151. Ramachandran, 2012, Horizontal transfer of RNAs: exosomes as mediators of intercellular communication, Wiley Interdiscip. Rev. RNA, 3, 286, 10.1002/wrna.115 · DOI
  152. Rao, 2013, MicroRNAs as biomarkers for CNS disease, Front. Mol. Neurosci., 6, 39, 10.3389/fnmol.2013.00039 · DOI · Paper page
  153. Rao, 2004, Identification of SNAREs involved in synaptotagmin VII-regulated lysosomal exocytosis, J. Biol. Chem., 279, 20471, 10.1074/jbc.M400798200 · DOI · Paper page
  154. Rebucci, 2015, miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1, Mol. Cancer, 14, 79, 10.1186/s12943-015-0349-6 · DOI
  155. Redell, 2009, Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes, J. Neurosci. Res., 87, 1435, 10.1002/jnr.21945 · DOI · Paper page
  156. Redell, 2010, Human traumatic brain injury alters plasma microRNA levels, J. Neurotrauma, 27, 2147, 10.1089/neu.2010.1481 · DOI
  157. Rekker, 2014, Comparison of serum exosome isolation methods for microRNA profiling, Clin. Biochem., 47, 135, 10.1016/j.clinbiochem.2013.10.020 · DOI
  158. Riancho, 2017, MicroRNA profile in patients with alzheimer’s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples, J. Alzheimers Dis., 57, 483, 10.3233/JAD-161179 · DOI · Paper page
  159. Rink, 2011, MicroRNA in ischemic stroke etiology and pathology, Physiol. Genomics, 43, 521, 10.1152/physiolgenomics.00158.2010 · DOI
  160. Rogers, 1996, Inflammation and Alzheimer’s disease pathogenesis, Neurobiol. Aging, 17, 681, 10.1016/0197-4580(96)00115-7 · DOI
  161. Salthouse, 2009, When does age-related cognitive decline begin?, Neurobiol. Aging, 30, 507, 10.1016/j.neurobiolaging.2008.09.023 · DOI · Paper page
  162. Santangelo, 2018, A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker, J. Neurooncol., 136, 51, 10.1007/s11060-017-2639-x · DOI
  163. Sanuki, 2011, miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression, Nat. Neurosci., 14, 1125, 10.1038/nn.2897 · DOI
  164. Sardi, 2011, Alzheimer’s disease, autoimmunity and inflammation. The good, the bad and the ugly, Autoimmun. Rev., 11, 149, 10.1016/j.autrev.2011.09.005 · DOI
  165. Satoh, 2013, Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH, Cell Metab., 18, 416, 10.1016/j.cmet.2013.07.013 · DOI
  166. Savina, 2003, Exosome release is regulated by a calcium-dependent mechanism in K562 cells, J. Biol. Chem., 278, 20083, 10.1074/jbc.M301642200 · DOI
  167. Schachter, 2009, Seizure disorders, Med. Clin. North Am., 93, 343, 10.1016/j.mcna.2008.10.001 · DOI
  168. Selmaj, 2017, Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis, Ann. Neurol., 81, 703, 10.1002/ana.24931 · DOI
  169. Sepramaniam, 2014, Circulating microRNAs as biomarkers of acute stroke, Int. J. Mol. Sci., 15, 1418, 10.3390/ijms15011418 · DOI
  170. Sharif, 2018, Delivery of exogenous miR-124 to glioblastoma multiform cells by Wharton’s jelly mesenchymal stem cells decreases cell proliferation and migration, and confers chemosensitivity, Stem Cell Rev., 14, 236, 10.1007/s12015-017-9788-3 · DOI
  171. Shi, 2010, MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity, Brain Res., 1352, 255, 10.1016/j.brainres.2010.07.009 · DOI
  172. Shi, 2015, Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients, Oncotarget, 6, 26971, 10.18632/oncotarget.4699 · DOI
  173. Shurtleff, 2016, Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction, Elife, 5, 10.7554/eLife.19276 · DOI · Paper page
  174. Silber, 2008, miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells, BMC Med., 6, 14, 10.1186/1741-7015-6-14 · DOI · Paper page
  175. Skog, 2008, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat. Cell Biol., 10, 1470, 10.1038/ncb1800 · DOI · Paper page
  176. Sorensen, 2016, miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia - an exploratory study, Transl. Neurodegener., 5, 6, 10.1186/s40035-016-0053-5 · DOI
  177. Sorensen, 2014, miRNA expression profiles in cerebrospinal fluid and blood of patients with acute ischemic stroke, Transl. Stroke Res., 5, 711, 10.1007/s12975-014-0364-8 · DOI
  178. Sowell, 2004, Mapping changes in the human cortex throughout the span of life, Neuroscientist, 10, 372, 10.1177/1073858404263960 · DOI · Paper page
  179. Squadrito, 2014, Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells, Cell Rep., 8, 1432, 10.1016/j.celrep.2014.07.035 · DOI · Paper page
  180. Stoorvogel, 1991, Late endosomes derive from early endosomes by maturation, Cell, 65, 417, 10.1016/0092-8674(91)90459-C · DOI
  181. Sun, 2015, MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1, Mol. Med. Rep., 12, 2355, 10.3892/mmr.2015.3657 · DOI
  182. Takeda, 2015, Neuronal differentiation of human mesenchymal stem cells using exosomes derived from differentiating neuronal cells, PLoS One, 10, 10.1371/journal.pone.0135111 · DOI
  183. Thery, 1999, Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73, J. Cell Biol., 147, 599, 10.1083/jcb.147.3.599 · DOI
  184. Thomson, 2011, Experimental strategies for microRNA target identification, Nucleic Acids Res., 39, 6845, 10.1093/nar/gkr330 · DOI · Paper page
  185. Thurman, 2011, Standards for epidemiologic studies and surveillance of epilepsy, Epilepsia, 52, 2, 10.1111/j.1528-1167.2011.03121.x · DOI
  186. Thushara Vijayakumar, 2016, Cerebral ischemic preconditioning: the road so far, Mol. Neurobiol., 53, 2579, 10.1007/s12035-015-9278-z · DOI
  187. Tian, 2014, A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, Biomaterials, 35, 2383, 10.1016/j.biomaterials.2013.11.083 · DOI
  188. Tokudome, 2015, Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation, Oncol. Lett., 10, 2269, 10.3892/ol.2015.3594 · DOI
  189. Trotta, 2018, Microglia-derived extracellular vesicles in Alzheimer’s Disease: a double-edged sword, Biochem. Pharmacol., 148, 184, 10.1016/j.bcp.2017.12.020 · DOI · Paper page
  190. Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol., 9, 654, 10.1038/ncb1596 · DOI · Paper page
  191. van den Boorn, 2011, SiRNA delivery with exosome nanoparticles, Nat. Biotechnol., 29, 325, 10.1038/nbt.1830 · DOI · Paper page
  192. van der Vos, 2016, Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain, Neuro Oncol, 18, 58, 10.1093/neuonc/nov244 · DOI · Paper page
  193. Vella, 2008, The role of exosomes in the processing of proteins associated with neurodegenerative diseases, Eur. Biophys. J., 37, 323, 10.1007/s00249-007-0246-z · DOI
  194. Vijayan, 2016, Peripheral biomarkers of stroke: focus on circulatory microRNAs, Biochim. Biophys. Acta, 1862, 1984, 10.1016/j.bbadis.2016.08.003 · DOI
  195. Villarroya-Beltri, 2013, Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs, Nat. Commun., 4, 2980, 10.1038/ncomms3980 · DOI · Paper page
  196. Vinish, 2011, Altered oxidative stress levels in Indian Parkinson’s disease patients with PARK2 mutations, Acta Biochim. Pol., 58, 165, 10.18388/abp.2011_2260 · DOI
  197. Visvanathan, 2007, The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development, Genes Dev., 21, 744, 10.1101/gad.1519107 · DOI · Paper page
  198. Vlassov, 2012, Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials, Biochim. Biophys. Acta, 1820, 940, 10.1016/j.bbagen.2012.03.017 · DOI
  199. Wang, 2014, MiR-122/Wnt/beta-catenin regulatory circuitry sustains glioma progression, Tumour Biol., 35, 8565, 10.1007/s13277-014-2089-4 · DOI
  200. Wang, 2008, Thymus exosomes-like particles induce regulatory T cells, J. Immunol., 181, 5242, 10.4049/jimmunol.181.8.5242 · DOI

200 of 228 shown

Cited by

Sorted by citations

See all 202

Metadata

Authors
Xia, X., Wang, Y., Huang, Y., Zhang, H., Lu, H., & Zheng, J. C.
Venue
Progress in Neurobiology
Publisher
Elsevier BV
Published
2019-12
Volume
183
Pages
101694
ISSN
0301-0082
DOI
10.1016/j.pneurobio.2019.101694
PMC
PMC7323939
Cited by
202
References
28
Language
en
Licence
Funders
  • National Natural Science Foundation of China
  • National Basic Research Program of China

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review